Manufacturing roundup: Cipla recalls albuterol doses over defect in the container; Cell and gene therapy manufacturer secures Series A
Drugmaker Cipla is pulling several batches of its albuterol off the shelves.
Last week, the drugmaker recalled six batches of albuterol …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
